These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25175066)

  • 41. Successful treatment of recurrent pancreatitis secondary to systemic lupus erythematosus with B-cell depletion therapy.
    Al-Musawi ZS; Nabar UJ
    Arch Iran Med; 2011 Jan; 14(1):66-70. PubMed ID: 21194267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT.
    Dominietto A; Tedone E; Soracco M; Bruno B; Raiola AM; Van Lint MT; Geroldi S; Lamparelli T; Galano B; Gualandi F; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 2012 Jan; 47(1):101-6. PubMed ID: 21460867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
    Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
    Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation.
    Chung BH; Hong YA; Sun IO; Piao SG; Kim JI; Moon IS; Choi BS; Park CW; Kim YS; Yang CW
    Ren Fail; 2012; 34(8):974-9. PubMed ID: 22817654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study.
    Chen H; Zheng W; Su J; Xu D; Wang Q; Leng X; Zhang W; Li M; Tang F; Zhang X; Zeng X; Zhao Y; Zhang F
    Rheumatology (Oxford); 2011 Sep; 50(9):1640-4. PubMed ID: 21571767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED; Travelstead AL; Barbosa J; Bergamini RA; Civitello L; Franz DN; Greffe BS; Hanson RD; Hurwitz CA; Kalinyak KA; Kelfer H; Khakoo Y; Mantovani JF; Nicholson SH; Sanders JM; Wegner S
    J Pediatr Hematol Oncol; 2006 Sep; 28(9):585-93. PubMed ID: 17006265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rituximab for uveitis.
    Miserocchi E; Pontikaki I; Modorati G; Bandello F; Meroni PL; Gerloni V
    Ophthalmology; 2011 Jan; 118(1):223-4. PubMed ID: 21199719
    [No Abstract]   [Full Text] [Related]  

  • 49. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab in a patient with multiple sclerosis--effect on B cells, plasma cells and intrathecal IgG synthesis.
    Petereit HF; Moeller-Hartmann W; Reske D; Rubbert A
    Acta Neurol Scand; 2008 Jun; 117(6):399-403. PubMed ID: 18031564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
    Longbrake EE; Cross AH
    JAMA Neurol; 2016 Feb; 73(2):219-25. PubMed ID: 26720195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab use in pediatric central demyelinating disease.
    Beres SJ; Graves J; Waubant E
    Pediatr Neurol; 2014 Jul; 51(1):114-8. PubMed ID: 24768216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
    von Essen MR; Ammitzbøll C; Hansen RH; Petersen ERS; McWilliam O; Marquart HV; Damm P; Sellebjerg F
    Brain; 2019 Jan; 142(1):120-132. PubMed ID: 30561509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosage of rituximab in systemic sclerosis: 2-year results of five cases.
    Moazedi-Fuerst FC; Kielhauser SM; Bodo K; Graninger WB
    Clin Exp Dermatol; 2015 Mar; 40(2):211-2. PubMed ID: 25250643
    [No Abstract]   [Full Text] [Related]  

  • 55. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
    Komori M; Lin YC; Cortese I; Blake A; Ohayon J; Cherup J; Maric D; Kosa P; Wu T; Bielekova B
    Ann Clin Transl Neurol; 2016 Mar; 3(3):166-79. PubMed ID: 27042677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
    Svenningsson A; Bergman J; Dring A; Vågberg M; Birgander R; Lindqvist T; Gilthorpe J; Bergenheim T
    Neurol Neuroimmunol Neuroinflamm; 2015 Apr; 2(2):e79. PubMed ID: 25745637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis.
    Baker D; Jacobs BM; Gnanapavan S; Schmierer K; Giovannoni G
    Mult Scler Relat Disord; 2019 Oct; 35():19-25. PubMed ID: 31279232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B-cell depletion therapy for multiple sclerosis.
    Miyazaki Y; Niino M
    Immunol Med; 2022 Jun; 45(2):54-62. PubMed ID: 34289331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Charcot Lecture | beating MS: a story of B cells, with twists and turns.
    Hauser SL
    Mult Scler; 2015 Jan; 21(1):8-21. PubMed ID: 25480864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab-induced serum sickness in multiple sclerosis patients.
    Wolf AB; Ryerson LZ; Pandey K; McGettigan BM; Vollmer T; Corboy JR; Alvarez E
    Mult Scler Relat Disord; 2019 Nov; 36():101402. PubMed ID: 31542710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.